Reviewing Organon & Co. (NYSE:OGN) & Basel Medical Group (NASDAQ:BMGL)

Basel Medical Group (NASDAQ:BMGL) and Organon & Co. (NYSE:OGN) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, analyst recommendations, risk, valuation and dividends.

Profitability

This table compares Basel Medical Group and Organon & Co.’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Basel Medical Group	N/A	N/A	N/A
Organon & Co.	3.01%	122.01%	6.74%

Analyst Ratings

This is a summary of current recommendations for Basel Medical Group and Organon & Co., as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Basel Medical Group	1	0	0	0	1.00
Organon & Co.	5	1	0	1	1.57

Organon & Co. has a consensus target price of $8.50, indicating a potential upside of 45.50%. Given Organon & Co.’s stronger consensus rating and higher possible upside, analysts clearly believe Organon & Co. is more favorable than Basel Medical Group.

Earnings and Valuation

This table compares Basel Medical Group and Organon & Co.”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Basel Medical Group	$8.90 million	1.15	-$9.50 million	N/A	N/A
Organon & Co.	$6.22 billion	0.24	$187.00 million	$0.71	8.23

Organon & Co. has higher revenue and earnings than Basel Medical Group.

Insider and Institutional Ownership

77.4% of Organon & Co. shares are owned by institutional investors. 1.4% of Organon & Co. shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Organon & Co. beats Basel Medical Group on 10 of the 11 factors compared between the two stocks.

About Basel Medical Group

Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore.

About Organon & Co.

Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.